Genetic polymorphisms of the human CYP2A13 gene: Identification of single-nucleotide polymorphisms and functional characterization of an Arg257Cys variant

Journal of Pharmacology and Experimental Therapeutics

Volumn 302, Issue 2, 2002, Pages 416-423

  Zhang, Xiuling ^a,b   Su, Ting ^a   Zhang, Qing Yu ^a   Gu, Jun ^a   Caggana, Michele ^a   Li, Hongming ^a   Ding, Xinxin ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b WADSWORTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; CYTOCHROME P450 2A13; CYTOCHROME P450 ISOENZYME; DNA; UNCLASSIFIED DRUG;

ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; ASIAN; CATALYSIS; CAUCASIAN; CONTROLLED STUDY; DNA POLYMORPHISM; DNA SEQUENCE; ENZYME ACTIVITY; ENZYME KINETICS; ETHNIC DIFFERENCE; ETHNIC GROUP; EXON; GENE FREQUENCY; GENETIC VARIABILITY; HUMAN; INTRON; MICHAELIS CONSTANT; NEGRO; NEWBORN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; SINGLE STRAND CONFORMATION POLYMORPHISM; STRUCTURE ACTIVITY RELATION; XENOBIOTIC METABOLISM;

AMINO ACID SUBSTITUTION; ARGININE; ARYL HYDROCARBON HYDROXYLASES; CONTINENTAL POPULATION GROUPS; CYSTEINE; CYTOCHROME P-450 ENZYME SYSTEM; DNA PRIMERS; HUMANS; KINETICS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; UNITED STATES; VARIATION (GENETICS);

EID: 0036070530     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.302.2.416     Document Type: Article

References (41)

1. Recommendations for a nomenclature system for human gene mutations
2. Exonic splicing enhancers: Mechanism of action, diversity and role in human genetic diseases
3. Identification of potential target genes for Adr1p through characterization of essential nucleotides in UAS1
4. Genetic polymorphism of cytochrome P450 3A5 in Chinese
5. Purification and characterization of two unique forms of cytochrome P-450 from rabbit nasal microsomes
6. Steroid metabolism by rabbit olfactory-specific P450 2G1
7. Purification and characterization of cytochrome P450 2E2 from hepatic microsomes of neonatal rabbits
8. The CYP2A gene subfamily: Species differences, regulation, catalytic activities and role in chemical carcinogenesis
9. A genetic polymorphism in coumarin 7-hydroxylation: Sequence of the human CYP2A genes and identification of variant CYP2A6 alleles
10. Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analyses of amino acid and coding nucleotide sequences
11. Purification and characterization of heterologously expressed mouse CYP2A5 and CYP2G1: Role in metabolic activation of acetaminophen and 2,6-dichlorobenzonitrile in mouse olfactory mucosal microsomes
12. Structure and function of cytochromes P450: A comparative analysis of three crystal structures
13. Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL
14. Organization, structure and evolution of the CYP2 gene cluster on human chromosome 19
15. CYP2A6 genetic polymorphisms and liver microsomal coumarin and nicotine oxidation activities in Japanese and Caucasians
16. CYP2A6*6, a novel polymorphism in cytochrome P450 2A6, has a single amino acid substitution (R128Q) that inactivates enzymatic activity
17. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression
18. Identification of key residues in rabbit liver microsomal cytochrome P450 2B4: Importance in interactions with NADPH-cytochrome P450 reductase
19. The structure of the cytochrome P450BM-3 haem domain complexed with the fatty acid substrate, palmitoleic acid
20. Baculovirus-mediated expression and characterization of rat CYP2A3 and human CYP2A6: Role in metabolic activation of nasal toxicants
21. A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes
22. Genetic polymorphisms of cytochrome P450 2A6 in a case-control study on lung cancer in a French population
23. A major role for CYP2A6 in nicotine C-oxidation by human liver microsomes
24. CYP2A6 gene deletion reduces susceptibility to lung cancer
25. The colorimetric estimation of formaldehyde by means of the Hantzsch reaction
26. A new deleted allele in the human cytochrome P450 2A6 (CYP2A6) gene found in individuals showing poor metabolic capacity to coumarin and (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride (SM-12502)
27. A new CYP2A6 gene deletion responsible for the in vivo polymorphic metabolism of (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride in humans
28. Homologous unequal cross-over within the human CYP2A gene cluster as a mechanism for the deletion of the entire CYP2A6 gene associated with the poor metabolizer phenotype
29. The carbon monoxide-binding protein of liver microsomes. I. Evidence for its hemoprotein nature
30. Identification and characterisation of novel polymorphisms in the CYP2A locus: Implications for nicotine metabolism
31. Characterisation and PCR-based detection of a CYP2A6 gene deletion found at a high frequency in a Chinese population
32. Evidence for cytochrome P450 2A6 and 3A4 as major catalysts for N′-nitrosonornicotine alpha-hydroxylation by human liver microsomes
33. Identification of a single nucleotide polymorphism in the TATA box of the CYP2A6 gene: Impairment of its promoter activity
34. The HOG pathway controls osmotic regulation of transcription via the stress response element (STRE) of the Saccharomyces cerevisiae CTT1 gene
35. Splice junctions, branch point sites, and exons: Sequence statistics, identification and applications to genome project
36. Characterization of human CYP2G genes: Widespread loss-of-function mutations and genetic polymorphism
37. Human cytochrome P450 CYP2A13: Predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone
38. Frequency of CYP2A6 gene deletion and its relation to risk of lung and esophageal cancer in the Chinese population
39. Variable CYP2A6-mediated nicotine metabolism alters smoking behavior and risk
40. Mammalian microsomal cytochrome P450 monooxygenase: Structural adaptations for membrane binding and functional diversity
41. Characterization of the cytochrome P450 CYP2J4: Expression in rat small intestine and role in retinoic acid biotransformation from retinal